La semaglutida es un agonista del receptor GLP-1 aprobado para el tratamiento de la diabetes tipo 2 y el manejo crnico del peso en pacientes con obesidad o sobrepeso
Why Leg Cramps May Occur During Wegovy Treatment Understanding the potential mechanisms behind leg cramps during Wegovy treatment requires consideration of both the medication's effects and the physiological changes associated with weight loss
Insurance companies and FSA administrators view GLP-1 therapy differently than elective procedures, recognizing it as treatment for a metabolic condition rather than cosmetic enhancement
I think it will overall benefit the health system with reducing costs related to obesity treatment, cardiovascular disease, said Dana Small, a neurology and neurosurgery professor at McGill University, according to a report from Global News
Multiple testing was addressed using false discovery rate (FDR) adjustment, and results were summarized with volcano plots generated in R
Can children or teenagers take GLP-1 agonists